Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Accuray Incorporated Signs Master Research And Collaboration Agreement With University Of Heidelberg
Accuray Incorporated announced the signing of a multi-year master research and collaboration agreement with the University of Heidelberg, a luminary research institution located in Heidelberg, Germany that contributes to the city's top international position in therapy, research and science. Accuray and the University of Heidelberg will collaborate on cutting-edge research in radiation oncology to advance treatment technology and provide health care professionals with the advanced tools for treating patients.
Latest Developments for Accuray Inc
- Accuray Inc Lowers FY 2013 Revenue Guidance-Conference Call
- Accuray Inc Reaffirms FY 2013 Revenue Guidance; Issues Q3 2013 Revenue Guidance In Line With Analysts' Estimates-Conference Call
- Accuray Inc Issues Q2 2013 Guidance; Revenue Guidance In Line With Analysts' Estimates; Lowers FY 2013 Guidance-Conference Call
- 90 Presentations At Radiation Oncology Meeting Demonstrate Breadth And Depth Of Clinical Evidence For Accuray Inc
Latest Key Developments in Advanced
- Varian Medical Systems Inc Receives FDA 510(k) Clearance Of Its Nexus DRF Digital X-Ray Imaging System
- Covidien PLC Announces Clinical Trial Data Showing Endoscopic Ablation Therapy Eliminates Precancerous Esophageal Tissue And Significantly Reduces Disease Progression
- Hologic Inc Receives FDA Approval For New Low-dose 3D Mammography (Breast Tomosynthesis) Solution For Breast Cancer Screening
- Echo Therapeutics Inc Announces Institutional Review Board (IRB) Approval For Clinical Trial Of Symphony CGM System
- Share this
- Link this
- Digg this
Follow Reuters